Journal ArticleOPEN ACCESS

Cognitive outcomes of anti‐amyloid‐β monoclonal antibodies in patients with Alzheimer's disease: A systematic review and meta‐analysis of randomized controlled trials

  • Fernandez P
  • Silva G
Alzheimer's & Dementia (2021) 17(S9)
DOI: 10.1002/alz.057778
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: For the last 20 years, the amyloid-beta (Aβ) cascade hypothesis has been

Cite

CITATION STYLE

APA

Fernandez, P. E. L., & Silva, G. D. (2021). Cognitive outcomes of anti‐amyloid‐β monoclonal antibodies in patients with Alzheimer’s disease: A systematic review and meta‐analysis of randomized controlled trials. Alzheimer’s & Dementia, 17(S9). https://doi.org/10.1002/alz.057778

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free